Piramal Pharma Q2 FY25 Results
Piramal Pharma has released its financial results for the Q2 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 2,241.75 Cr
- Quarter-on-Quarter (QoQ) Change: 14.89% (Previous Quarter: Rs. 1,951.14 Cr )
- Year-on-Year (YoY) Change: 17.28% (Same Quarter Last Year: Rs. 1,911.38 Cr )
Profitability Metrics
- Net Profit: Rs. 22.59 Cr
- QoQ Profit Change: -125.49% (Previous Quarter: Rs. -88.64 Cr )
- YoY Profit Change: 350.00% (Same Quarter Last Year: Rs. 5.02 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 0.17
- QoQ EPS Change: -125.37% (Previous Quarter: Rs. -0.67)
- YoY EPS Change: 325.00% (Same Quarter Last Year: Rs. 0.04)
Performance Summary
Excellent
Piramal Pharma did very well, with profits growing faster than sales. This means they're managing costs better.
This analysis provides a snapshot of Piramal Pharma's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.